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Abstract: In order to distribute dengue IgM-capture ELISA to the peripheral
laboratories, supply of key reagents should be established by local production. In this
study, comparative IgM-capture ELISA was carried out on a total of 237 sera using
key reagents from 2 sources. The current set consisted of suckling mouse brain
(SMB)-derived dengue type 2 (D2) antigen and a D2 monoclonal antibody (MAb)
supplied from the United States. While an alternative set was supplied by one of the
authors, consisting of tissue culture-derived dengue antigen (TCA) and MAb es-
tablished in USM.
When the IgM-ELISA results were compared with those by the hemag-
glutination-inhibition (HI) test as a gold standard, the sensitivity was 50.0% by the
current set and 75.0% by the alternative set of reagents, respectively. While the
specificity was 95.2% by the current set and 90.3% by the alternative set of reagents.
The results showed that the alternative set of reagents can effectively be used in
dengue IgM-ELISA and is significantly more sensitive than the current set of rea-
gents (Chi SQR=12.26, P<0.01) at less than 1% risk. However there is no significant
difference in specificity between the two reagents (Chi SQR=2.45, 0.5>P>0.1) at
10% risk.
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INTRODUCTION
Dengue fever (DF) and dengue haemorrhagic fever (DHF) have been major health problems
in many tropical countries especially in Southeast Asia (Halstead, 1966; 1980; 1992; W∝Id Health
Received for Publication, October 2, 1995
contribution No. 3169 from the Institute of Tropical Medicine, Nagasaki University
110
organization, 1966). Till the advent of modern serological techniques, the haemag-
glutination-inhibition (HI) test was used in the laboratory diagnosis of dengue (Clarke and
casals, 1958; Shope and Sather, 1979; World Health Organization, 1986). This test, which is still
used as the gold standard, is relatively laborious, time-consuming and requiring paired serum
specimens. Introduction of the lgM-capture ELISA was a significant advance in the dengue
serology (Burke, 1983; Bundo and lgarashi, 1985; Lam et al, 1987; Innis et al, 1989). However,
it still needs improvements especially in the supply of key reagents such as assay antigens and
dengue monoclonal antibodies (MAb), before the test can be routinely used in the peripheral
laboratories. A simplified version of dengue antibody assay in a dot-blot test is currently com-
mercially available, but it appears to lack sensitivity to detect primary dengue cases and is also
quite expensive (Fang et al, 1992).
In the Virology Division, Institute for Medical Research (IMR), Malaysia, in -house dengue
lgM - capture ELISA was established according to the method of Lam et al. (1987), which greatly
increased efficiency and sensitivity in the serological diagnosis on dengue. Two major reagents in
this test are dengue antigens and dengue MAb. The antigens are prepared from infected suckling
mouse brains (8MB) by sucrose -acetone extraction (Clarke and Casals, 1958), and dengue MAb
is supplied on a limited basis by kind courtesy from Centres for Disease Control and Prevention,
Division of Vector-Borne Infectious Diseases, Ft. Collins, CO, USA. The limitation in the supply
of these 2 reagents has made it difficult to decentralize the dengue lgM-ELISA to peripheral
laboratories in Malaysia.
one of the authors to this paper (Jane Cardosa), raised the dengue antigen in tissue culture
(TCA), and dengue MAb in her own laboratory. If these reagents can be utilized as an alternative
set in the dengue lgM - ELISA, the results will greatly facilitate the decentralization of the test,
leading to the better efficiency in the laboratory diagnosis and epidemiological surveillance, and
eventually to the effective control of dengue.
MATERIALS AND METHODS
Antigens: Two sources of antigens were used: suckling mouse brain- derived antigen (SMB),
and tissue culture-derived antigen (TCA). The 8MB antigen of dengue type 2 virus (D2) was
prepared in the Division of Virology, IMR, by sucrose-acetone extraction method (Clarke and
casals, 1958). The TCA was prepared as a cocktail of 4 types of dengue virus antigens prepared
in the infected C6/36 cell cultures (Igarashi, 1978).
Monoclonal antibody (MAb): Two kinds of MAb used in this study were: antトD2 MAb
3H5-ト2トB71541 kindly provided by Dr Nick Karabatsos, CDC, Ft. Collins, CO, and dengue
cross-reactive MAb MF4/5/A5/C3-3 provided by one of the authors (Jane Cardosa).
serum specimens: A total of 237 paired sera were previously examined by the HI test ac-
cording to the standard method (Clarke and Casals, 1958; Shope and Sather, 1979; World Health
organization, 1986), showing 92 positives and 145 negatives. The convalescent phase sera from
each pair were used in this study of lgM-ELISA after storage a卜20℃･
IgM-capture ELISA: The modified method of Lam et al (1987) was used with reaction period
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of 1 hour at 37℃ except the last step. A 96-well U-bottom plate was sensitized with an-
tトhuman lgM (Dakopatts, Denmark). After washing, the plate was reacted with test sera diluted
1:100 in PBS-Tween in duplicate wells for each specimen, along with a standard positive and a
standard negative specimens. After incubation and washing, the plate was successively reacted
with dengue antigen, followed by dengue MAb, then horseradish peroxidase-conjugated an-
tトmouse lgG (Bio Rad, Canada), which is free from cross reaction to human immunoglobulins.
After the last washing, peroxidase reaction was carried out for 30 minutes using a substrate so-
lution of o-phenylenediamine and hydrogen peroxide. The peroxidase reaction was stopped by
adding 4N sulphuric acid, and absorbance at 490 nm was measured by a Dynatech MR5000
ELISA reader using 630 nm as a reference wavelength.
Interpretation of the results: The 92 HI positives were classified into the following cate-
gones according to the WHO criteria;
1. Primary infection-4-fold rise or more in titre, interval between specimens of 〓 7 days,
maximum titre of 〓 1280.
2. Secondary infection-4-fold rise or more in titre, interval between specimens any number of
days, maximum titre of 〓 2560.
3. Presumptive secondary infection-No 4-fold rise in titre, interval between specimens any
number of days, maximum titre of 〓 2560.
4. Definite infection-4-fold rise or more in titre, interval between specimens of < 7 days,
maximum titre of 〓 1280.
The positive to negative ratio (P/N ratio) was calculated by dividing the average absorbance
in duplicate sample wells by the average absorbance in the negative standard. Any specimens
with P/N ratio equal to or greater than 2.0 were considered positive. The sensitivity and specif-
icity of the tests were calculated by the following formula:
Sensitivity -
Specificity -
Number of true positive
Number of true positive + false negative
Number of true negative
Number of true negative + false positive
RESULTS AND DISCUSSION
The results of comparative lgM-ELISA using 2 sets of reagents were shown in Tables 1
and 2. The sensitivity and specificity of the tests were calculated to see the significance of their
difference. The alternative set of TCA antigen and MF4-MAb showed sensitivity of 75.(
which was higher than the value (50.0%) for the set of 8MB antigen and D2-MAb which is
currently used in IMR. This difference was statistically significant (CHI SQR- 12.26, p< 0.01) at
less than l% risk. While the TCA antigen and MF4-MAb showed specificity of 90.3% which is
less than the value (95.2%) for 8MB antigen and D2-MAb. However this difference was not
statistically significant (CHI SQR-2.45, 0.5 >P >0.1) at lO% risk.
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comparison of the lgM-ELISA using 8MB antigen and
D2-MAb with the HI as standard.






Sensitivity- 46/92 × 100 - 50.0%
Specificity- 138/145 × 100 - 95.2%
Table 2　Comparison of the lgM-ELISA using TCA antigen and
MF4-MAb with the HI as the standard.
IgM-ELISA with TCA antigen and MF4-MAb
p ositive negative total
HI
positive　　　　　　69　　　　　　　2 3




sensitivity - 69/92 × 100 - 75.0%
Specificity- 131/145 × 100-90.3%
There is a significant difference in the percentage of positives for definite infection (see
Table 3) between 8MB antigen/D2-MAb, 45.9% and, TCA/MF4-MAb, 71.6% (CHI
sQR= 10.07) at less than l% risk. Although the day of interval between samples were mostly not
available to us, the inability of 8MB antigen/D2-MAb to pick up more definite infection in this
case is that most of the samples were probably primary infection. The limitations being that the
SMB antigen is a D2 antigen and the monoclonal antibody used was D2 specific monoclonal an-
tibody which fails to pick up primary infection of other serotypes. However there is no significant
difference in the percentage of positives for secondary infection between the two reagents; SMB
antigen/02-MAb, 70.69及b and TCA antigen/MF4-MAb, 88.2% (CHI SQR- 1.62, 0.5>P>0.1)
at lO% risk.

















A suitable laboratory test for early confirmation of symptomatic dengue or undifferentiated
fever cases has been shown to be an effective first line screening test (Burke, 1983; Bundo and
lgarashi, 1985; Lam et al, 1987; Innis et al, 1989). However, its use has been confined to refer-
ence laboratories since some reagents were not easily available. Our study showed that the TCA
antigen and MF4｢ MAb can be used with a better sensitivity without losing significant specificity
of currently used 8MB-derived D2 antigen and MAb solicited from the USA. The next step in
this study will be to use a cocktail of antigen produced in IMR since all four types of dengue
antigen are produced here and a cross -reacting monoclonal antibody. With strong possibility to
produce these reagents in quantities locally, the modified dengue lgM-capture ELISA could be
introduced to the peripheral health centres. This decentralization, when carried out through
technical transfer from the central reference laboratory such as IMR, will greatly enhance
laboratory diagnosis, surveillance and control of DF/DHF in Malaysia.
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